Baxter International

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

New Dividend: 45 cents per share

Dividend Percent Increase: 34.3%

Current Yield: 3.12%

It's been a stellar year for shareholders of Baxter International ( BAX) -- the medical supply maker has seen its shares rally more than 16% so far in 2012, easily outperforming the broad market. And that's before dividends.

>>10 Best-Performing S&P 500 Stocks in the Second Quarter

Baxter is a leader in the injectable therapies market, manufacturing everything from IV bags and solutions to dialysis equipment. The company also has a fast-growing BioScience unit that's been tackling therapies for a number of specialized disorders that don't get targeted by generic drug makers.

With the firm's 34.3% dividend hike on Wednesday, this stock now yields 3.12%. Income investors looking for a diversified core holding in the healthcare industry could do worse than this stock.

If you liked this article you might like

Stocks Sharply Lower on North Korea Missile Launch Over Japan

Tiny Store America

Simon Property Settles Antitrust Investigation in New York

Zombieland No More -- These New Retailers Are Invading Dying Malls

Apple Has Triggered This Major Phenomenon That Is Preventing Many Malls From Dying